Astec LifeSciences Limited (ASTEC) Q2 FY27 Financial Results: PAT ₹-18.7 & Revenue ₹84.3
Investor Takeaways
Overall Tone: Neutral based on the numbers only.
Key Financial Highlights
| Metric | Value | YoY Change |
|---|---|---|
| Revenue | ₹84.3 Cr | -8% |
| Net Profit | ₹-18.7 Cr | Improved from ₹-33.0 Cr |
| EBITDA | ₹0.1 Cr | Improved from -₹10.5 Cr |
| EPS | Not available | |
| OPM | Not available |
What Changed
The filing reports consolidated revenue of ₹84.3 crore for Q1FY27, representing an 8% year-on-year decline from ₹91.6 crore. Despite the revenue contraction, EBITDA turned positive at ₹0.1 crore compared to a ₹10.5 crore loss in the same quarter last year. The net loss also narrowed significantly to ₹-18.7 crore from ₹-33.0 crore YoY. These improvements indicate progress in cost management and operational efficiency, even amid lower sales volume. The company achieved EBITDA breakeven, signaling potential stabilization in core operations. Quarterly trends show sequential improvement in profitability metrics, with Q1FY27 EBITDA positive for the first time in recent quarters.
Peer Comparison
| Company | P/E | ROE | ROCE | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Astec LifeSciences | -11.26 | N/A | N/A | 1,505.83 |
| Solar Industries India | 132.27 | N/A | N/A | 1,56,674.48 |
| Pidilite Industries | 75.73 | N/A | N/A | 1,49,378.89 |
| SRF Limited | 69.51 | N/A | N/A | 79,723.46 |
Astec LifeSciences trades at a negative P/E ratio, reflecting its current un profitability, while peers exhibit positive valuations. The company's market capitalization is significantly lower than the largest peer, indicating a smaller market presence.
Risks & Concerns
No specific risks identified in this filing.
Quarterly Trend
| Quarter | Revenue (₹ Cr) | Net Profit (₹ Cr) | OPM% |
|---|---|---|---|
| Q3FY25 | 93.86 | -40.37 | -6.12 |
| Q2FY25 | 98.55 | -38.55 | -20.03 |
| Q1FY25 | 69.37 | -39.72 | -66.69 |
| Q4FY24 | 153.75 | -0.96 | 8.27 |
About Astec LifeSciences Limited (ASTEC)
Chemicals · Fertilizers & Agrochemicals · Listed on NSE
📡 Get AI alerts when ASTEC files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ASTEC — Free💡 Ask AI about this filing
📊 More ASTEC filings
- share transfer — 15 July 2026 Astec LifeSciences received a compliance certificate from its share transfer agent confirming adhere...
- 🔴 Annual Report — 8 July 2026 The Annual Report 2025-26 for Astec LifeSciences Limited (NSE: ASTEC) details FY2025-26 financial pe...
- 🔴 Annual Report — 8 July 2026 The 32nd Annual General Meeting of Astec LifeSciences Limited is scheduled for 31 July 2026 via vide...
- 🟡 Board Meeting — 4 July 2026 No summary available
- 🟡 Voting Results — 4 July 2026 The company announced the results of a postal ballot vote held on July 4, 2026, confirming the passa...
🔥 Also filed on 31 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ASTEC files new disclosures
Track ASTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ASTEC — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research